An international study co-authored by McGill psychologist Caroline Palmer suggests our brains and bodies don’t just understand music, they physically resonate with it. These discoveries, based on findings in neuroscience, music, and psychology, support Neural […]
When a family member or friend gets sick or injured, it’s easy to feel powerless: What do you say? How do you help? When should you check in, and how often? How much is too […]
Black and Hispanic children with high-risk neuroblastoma experience worse survival outcomes than their white peers, even when treated in frontline clinical trials, according to a study led by a UT Southwestern Medical Center researcher.This article […]
An investigational blood test for type 1 diabetes can accurately detect the disorder’s characteristic autoimmunity with only small samples of blood, a feature that makes it ideal to screen pediatric patients, scientists in Australia report […]
The use of nicotine pouches—small, easily concealed sachets of nicotine and additives that are placed between the gum and lip—nearly doubled among U.S. high school students between 2023 and 2024, according to a new USC […]
Recently approved Alzheimer’s drugs offer a step forward for treating the disease, but new therapeutic strategies are needed to complement them and provide personalized therapeutic approaches. Mass General Brigham researchers have identified a potential strategy […]
Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of human blood development, improving understanding of leukemia formation and enabling a more precise classification of acute leukemia.This article was originally […]
Australia’s recent move to lower the starting age for bowel (colorectal) cancer screening from 50 down to 45 years old will mean better outcomes—but it will also increase the burden on an already struggling health […]
An international research team led by Geneva University Hospital found no increase in cardiovascular events during the first two years of treatment with Janus kinase inhibitors (JAKi) compared to tumor necrosis factor inhibitors (TNFi) in […]
New research from SAHMRI and Flinders University has shed light on how the decades-old antipsychotic drug, trifluoperazine (TFP), works against glioblastoma (GBM), the most aggressive form of brain cancer.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca